{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:23:39Z","timestamp":1787027019479,"version":"build-2736575974"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00781","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T07:11:58Z","timestamp":1534230718000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["A Nanomicellar Prodrug Carrier Based on Ibuprofen-Conjugated Polymer for Co-delivery of Doxorubicin"],"prefix":"10.3389","volume":"9","author":[{"given":"Zuojun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieni","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongfeng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kechao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/11024159850191544","article-title":"Colon cancer prevention by NSAIDs: what is the mechanism of action?","volume":"164","author":"Ahnen","year":"1998","journal-title":"Eur. J. Surg."},{"key":"B2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00280-002-0485-8","article-title":"Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells.","volume":"50","author":"Andrews","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/tpj.2010.55","article-title":"Changes in the gene expression profile of gastric cancer cells in response to ibuprofen: a gene pathway analysis.","volume":"11","author":"Bonelli","year":"2011","journal-title":"Pharmacogenomics J."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13443","article-title":"An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy.","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in cancer.","volume":"14","author":"Cho","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1166\/jbn.2013.1608","article-title":"Novel composed galactosylated nanodevices containing a ribavirin prodrug as hepatic cell-targeted carriers for HCV treatment.","volume":"9","author":"Craparo","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/annonc\/mdf125","article-title":"Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.","volume":"13","author":"Davies","year":"2002","journal-title":"Ann. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00280-005-0048-x","article-title":"Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro.","volume":"57","author":"Dial","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.550","article-title":"Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70.","volume":"5","author":"Endo","year":"2014","journal-title":"Cell Death Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000071373","article-title":"Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis.","volume":"37","author":"Gately","year":"2003","journal-title":"Prog. Exp. Tumor. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jconrel.2005.09.034","article-title":"Block copolymer micelles: preparation, characterization and application in drug delivery.","volume":"109","author":"Gaucher","year":"2005","journal-title":"J. Control Release"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/bm4009149","article-title":"Preparation of well-defined ibuprofen prodrug micelles by RAFT polymerization.","volume":"14","author":"Hasegawa","year":"2013","journal-title":"Biomacromolecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.bbrc.2007.11.051","article-title":"p53 is important for the anti-proliferative effect of ibuprofen in colon carcinoma cells.","volume":"365","author":"Janssen","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"4830","DOI":"10.1021\/ja809475a","article-title":"Multi-stimuli sensitive amphiphilic block copolymer assemblies.","volume":"131","author":"Klaikherd","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7150\/thno.7193","article-title":"Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?","volume":"4","author":"Kobayashi","year":"2014","journal-title":"Theranostics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jconrel.2015.04.003","article-title":"Liposomal delivery systems for anti-cancer analogues of vitamin E.","volume":"207","author":"Koudelka","year":"2015","journal-title":"J. Control Release"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/j.nano.2016.05.012","article-title":"Spherical polymeric nanoconstructs for combined chemotherapeutic and anti-inflammatory therapies.","volume":"12","author":"Lee","year":"2016","journal-title":"Nanomedicine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mabi.201100083","article-title":"Development of disulfide core-crosslinked pluronic nanoparticles as an effective anticancer-drug-delivery system.","volume":"11","author":"Lee","year":"2011","journal-title":"Macromol. Biosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0006-2952(99)00200-2","article-title":"Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines.","volume":"58","author":"Lim","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1021\/nn200809t","article-title":"Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model.","volume":"5","author":"Meng","year":"2011","journal-title":"ACS Nano"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2017.06.003","article-title":"Nanoformulations for combination or cascade anticancer therapy.","volume":"115","author":"Miao","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0168-3659(01)00342-X","article-title":"Tumour targeted delivery of encapsulated dextran\u2013doxorubicin conjugate using chitosan nanoparticles as carrier.","volume":"74","author":"Mitra","year":"2001","journal-title":"J. Control Release"},{"key":"B23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.addr.2012.09.026","article-title":"Advanced drug delivery devices via self-assembly of amphiphilic block copolymers.","volume":"64","author":"R\u00f6sler","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1039\/C5TB02053K","article-title":"PEG based anti-cancer drug conjugated prodrug micelles for the delivery of anti-cancer agents.","volume":"4","author":"Senevirathne","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1021\/ja909475m","article-title":"Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery.","volume":"132","author":"Shen","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1054-3589(08)60067-8","article-title":"Colorectal cancer and nonsteroidal anti-inflammatory drugs.","volume":"39","author":"Smalley","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/aps.2017.44","article-title":"Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier.","volume":"38","author":"Sun","year":"","journal-title":"Acta Pharmacol. Sin."},{"key":"B28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jconrel.2017.05.006","article-title":"Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy.","volume":"258","author":"Sun","year":"","journal-title":"J. Control Release"},{"key":"B29","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.actbio.2016.07.014","article-title":"A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.","volume":"43","author":"Sun","year":"","journal-title":"Acta Biomater."},{"key":"B30","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/0885328216642665","article-title":"Intracellular plasmid DNA delivery by self-assembled nanoparticles of amphiphilic PHML-b-PLLA-b-PHML copolymers and the endocytosis pathway analysis.","volume":"31","author":"Sun","year":"","journal-title":"J. Biomater. Appl."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.08.263","article-title":"Preparation of cationic l-lysine conjugated poly (2-hydroxyethyl methacrylate) s and their potential application as low cytotoxic efficient gene delivery vectors.","volume":"172","author":"Sun","year":"","journal-title":"J. Control Release"},{"key":"B32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/mabi.201200304","article-title":"Preparation of functional water-soluble low-cytotoxic poly(methacrylate)s with pendant cationic l-lysines for efficient gene delivery.","volume":"13","author":"Sun","year":"","journal-title":"Macromol. Biosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4258","DOI":"10.1039\/C5PY00497G","article-title":"Facile synthesis of drug-conjugated PHPMA core-crosslinked star polymers.","volume":"6","author":"Tucker","year":"2015","journal-title":"Polym. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrc1801","article-title":"Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics.","volume":"6","author":"Ulrich","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1039\/C4BM00065J","article-title":"A facile strategy to prepare redox-responsive amphiphilic PEGylated prodrug with high drug loading content and low critical micelle concentration.","volume":"2","author":"Wang","year":"2014","journal-title":"Biomater. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1021\/acs.biomac.5b01227","article-title":"Amphiphilic diblock terpolymer PMAgala-b-P (MAA-co-MAChol) s with attached galactose and cholesterol grafts and their intracellular pH-responsive doxorubicin delivery.","volume":"17","author":"Wang","year":"2015","journal-title":"Biomacromolecules"},{"key":"B37","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1039\/C6PY01526C","article-title":"Synthesis and self-assembly of diblock glycopolypeptide analogues PMAgala-b-PBLG as multifunctional biomaterials for protein recognition, drug delivery and hepatoma cell targeting.","volume":"8","author":"Wang","year":"2017","journal-title":"Polym. Chem."},{"key":"B38","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.progpolymsci.2012.07.002","article-title":"Design and development of polymeric micelles with cleavable links for intracellular drug delivery.","volume":"38","author":"Wei","year":"2013","journal-title":"Prog. Polym. Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1021\/mp500181x","article-title":"PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.","volume":"11","author":"Zhang","year":"2014","journal-title":"Mol. Pharm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1021\/acs.bioconjchem.6b00415","article-title":"PEG-fmoc-ibuprofen conjugate as a dual functional nanomicellar carrier for paclitaxel.","volume":"27","author":"Zhao","year":"2016","journal-title":"Bioconjug. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00781\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T07:12:00Z","timestamp":1534230720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.00781\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":40,"alternative-id":["10.3389\/fphar.2018.00781"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00781","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"article-number":"781"}}